On November 2, 2009, Salix Pharmaceuticals, Ltd. issued a press release announcing that the 60th Annual Meeting of the American Association for the Study of Liver Diseases, being held in Boston, MA, Saturday, October 31 - Tuesday, November 3, 2009, is the venue for two presentations describing the investigation of rifaximin for the maintenance of remission from hepatic encephalopathy. A copy of this press release is attached as Exhibit 99.1.

On November 3, 2009, Salix issued a press release announcing the issuance of a patent by the United States Patent and Trademark Office, entitled "Polymorphic Forms Alpha, Beta, and Gamma of Rifaximin". A copy of this press release is attached as Exhibit 99.2.

On November 4, 2009, Salix issued a press release announcing that it will present at the 2009 Credit Suisse Healthcare Conference in Phoenix, AZ on Wednesday, November 11 at 3:30 p.m. MT/5:30 p.m. ET. A copy of this press release is attached as Exhibit 99.3.

Also on November 4, 2009, Salix issued a press release announcing that it will host an Analyst Day on Wednesday, November 18, 2009 from 10:00 a.m. to 12:00 noon Eastern Time. A copy of this press release is attached as Exhibit 99.4.

(d) Exhibits

               Exhibit No.   Description

                  99.1       Press release dated November 2, 2009.

                  99.2       Press release dated November 3, 2009.

                  99.3       Press release dated November 4, 2009.

                  99.4       Press release dated November 4, 2009.